These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32946877)

  • 1. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
    Bornert O; Hogervorst M; Nauroy P; Bischof J; Swildens J; Athanasiou I; Tufa SF; Keene DR; Kiritsi D; Hainzl S; Murauer EM; Marinkovich MP; Platenburg G; Hausser I; Wally V; Ritsema T; Koller U; Haisma EM; Nyström A
    J Invest Dermatol; 2021 Apr; 141(4):883-893.e6. PubMed ID: 32946877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
    Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
    J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy.
    Bornert O; Kühl T; Bremer J; van den Akker PC; Pasmooij AM; Nyström A
    Mol Ther; 2016 Aug; 24(7):1302-11. PubMed ID: 27157667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients.
    Goto M; Sawamura D; Nishie W; Sakai K; McMillan JR; Akiyama M; Shimizu H
    J Invest Dermatol; 2006 Dec; 126(12):2614-20. PubMed ID: 16778792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.
    Berthault C; Gaucher S; Gouin O; Schmitt A; Chen M; Woodley D; Titeux M; Hovnanian A; Izmiryan A
    J Invest Dermatol; 2024 Jun; 144(6):1322-1333.e13. PubMed ID: 38043638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
    Dang N; Klingberg S; Marr P; Murrell DF
    J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Condorelli AG; Logli E; Cianfarani F; Teson M; Diociaiuti A; El Hachem M; Zambruno G; Castiglia D; Odorisio T
    Br J Dermatol; 2019 Nov; 181(5):1017-1027. PubMed ID: 30816994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
    Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
    JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa.
    Cianfarani F; Zambruno G; Castiglia D; Odorisio T
    Am J Pathol; 2017 Jul; 187(7):1445-1453. PubMed ID: 28460207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa.
    Koga H; Hamada T; Ishii N; Fukuda S; Sakaguchi S; Nakano H; Tamai K; Sawamura D; Hashimoto T
    J Dermatol; 2011 May; 38(5):489-92. PubMed ID: 21352278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
    Dang N; Murrell DF
    Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin.
    Bremer J; van den Akker PC
    Methods Mol Biol; 2022; 2434():185-190. PubMed ID: 35213017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation in italian patients with dystrophic epidermolysis bullosa.
    Gardella R; Castiglia D; Posteraro P; Bernardini S; Zoppi N; Paradisi M; Tadini G; Barlati S; McGrath JA; Zambruno G; Colombi M
    J Invest Dermatol; 2002 Dec; 119(6):1456-62. PubMed ID: 12485454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
    Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical spectrum of dystrophic epidermolysis bullosa.
    Horn HM; Tidman MJ
    Br J Dermatol; 2002 Feb; 146(2):267-74. PubMed ID: 11903238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
    Woodley DT; Hao M; Kwong A; Levian B; Cogan J; Hou Y; Mosallaei D; Kleinman E; Zheng K; Chung C; Kim G; Peng D; Chen M
    Br J Dermatol; 2024 Jul; 191(2):267-274. PubMed ID: 38366625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
    Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
    J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa.
    Wang X; Alshehri F; Manzanares D; Li Y; He Z; Qiu B; Zeng M; A S; Lara-Sáez I; Wang W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884578
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.